September 2025 Archive
UM Ventures, Baltimore Newsletter | Summer/Fall 2025
Tuesday, September 9, 2025
Have an invention?Disclose it to the UM Ventures, Baltimore team. Featured Article UM Ventures, Baltimore Announces Investment in GEn1E Lifesciences The UM Ventures, Baltimore (UMVB) equity investment program is delighted to partner with GEn1E Lifesciences through its participation in the company’s... read more
UMB Patent Awards | April - June 2025
Tuesday, September 9, 2025
B4GALT1 Variants And Uses ThereofJapanese patent issued on April 4, 2025, and Mexican patent issued on May 19, 2025 UMB Inventor: May Montasser, PhD (UMSOM) Multivalent Vaccines for Rabies Virus and CoronovirusesU.S. Continuation issued on April 8, 2025 UMB Inventors: Matthew Frieman, PhD, (... read more
President’s Entrepreneurial Fellowship Alumni Profile: Ryan Mayers, PhD Candidate ‘25
Tuesday, September 9, 2025
Ryan Mayers, a PhD candidate in neuroscience at the University of Maryland School of Medicine (UMSOM), has been able to advance his varied interests in research, science policy, and social behavior through diverse training experiences offered by the University of Maryland, Baltimore (UMB),... read more
Featured Partner: Protaryx Medical, Inc.
Tuesday, September 9, 2025
A member of Baltimore’s thriving medical technology community, Protaryx Medical is on a mission to redefine the future of cardiac intervention. The venture-backed medical device startup spun out of the University of Maryland, Baltimore (UMB) in 2019 to accelerate commercialization of a... read more
UMVB Announces Investment in GEn1E Lifesciences
Tuesday, September 9, 2025
The UM Ventures, Baltimore (UMVB) equity investment program is delighted to partner with GEn1E Lifesciences through its participation in the company’s Series Seedplus financing, marking the program’s 20th investment. GEn1E Lifesciences (GEn1E Lifesciences) is a biotechnology company founded in 2018... read more